PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: Implications for the treatment of negative symptoms in schizophrenia-Reference-Cited by-同舟云学术

PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: Implications for the treatment of negative symptoms in schizophrenia

Published:2011-01 Issue:1 Volume:125 Page:88-92
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Dyck Bailee,Guest Kelly,Sookram Christal,Basu Dipannita,Johnson Rodney,Mishra Ram K.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference44 articles.

1. Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats;Bast;Pharmacol. Biochem. Behav.,2000

2. Comparison of amphetamine psychosis and schizophrenia;BELL;Br. J. Psychiatry,1965

3. Dopamine agonists in schizophrenia: a review;Benkert;Eur. Neuropsychopharmacol.,1995

4. A comparative review of new antipsychotics;Blin;Can. J. Psychiatry,1999

5. MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats;Castellano;Peptides,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II involvement in the development and persistence of amphetamine‐induced sensitization: Striatal dopamine reuptake implications;European Journal of Neuroscience;2024-03-13

2. Review on allosteric modulators of dopamine receptors so far;Health Science Reports;2024-03

3. Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis;Molecules;2022-12-25

4. Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators;Frontiers in Chemistry;2021-10-07

5. Effect of Chronic Treatment with D2 Allosteric Modulator PAOPA on the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) in Select Brain Regions;International Journal of Peptide Research and Therapeutics;2021-08-19